23-09-2021, 03:26 PM
Valneva continues discussions with the European Commission regarding a potential VLA2001 supply contract. The Company is also actively pursuing opportunities to make VLA2001 available to other customers, subject to positive Cov-Compare data and regulatory approval.
[/url][url=https://valneva.com/press-release/valneva-continues-expansion-of-clinical-trials-of-its-inactivated-covid-19-vaccine-candidate-vla2001/]Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001 – Valneva
[/url][url=https://valneva.com/press-release/valneva-continues-expansion-of-clinical-trials-of-its-inactivated-covid-19-vaccine-candidate-vla2001/]Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001 – Valneva